1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Marine Biopharmaceutical Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Drugs 1.2.3 Health Supplement 1.3 Market by Application 1.3.1 Global Marine Biopharmaceutical Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital & Clinic 1.3.3 Pharmacy 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Marine Biopharmaceutical Market Size (2017-2028) 2.2 Marine Biopharmaceutical Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Marine Biopharmaceutical Market Size by Region (2017-2022) 2.4 Global Marine Biopharmaceutical Market Size Forecast by Region (2023-2028) 2.5 Global Top Marine Biopharmaceutical Countries Ranking by Market Size 3 Marine Biopharmaceutical Competitive by Company 3.1 Global Marine Biopharmaceutical Revenue by Players 3.1.1 Global Marine Biopharmaceutical Revenue by Players (2017-2022) 3.1.2 Global Marine Biopharmaceutical Market Share by Players (2017-2022) 3.2 Global Marine Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Marine Biopharmaceutical Revenue 3.4 Global Marine Biopharmaceutical Market Concentration Ratio 3.4.1 Global Marine Biopharmaceutical Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Marine Biopharmaceutical Revenue in 2021 3.5 Global Marine Biopharmaceutical Key Players Head office and Area Served 3.6 Key Players Marine Biopharmaceutical Product Solution and Service 3.7 Date of Enter into Marine Biopharmaceutical Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Marine Biopharmaceutical Breakdown Data by Type 4.1 Global Marine Biopharmaceutical Historic Revenue by Type (2017-2022) 4.2 Global Marine Biopharmaceutical Forecasted Revenue by Type (2023-2028) 5 Global Marine Biopharmaceutical Breakdown Data by Application 5.1 Global Marine Biopharmaceutical Historic Market Size by Application (2017-2022) 5.2 Global Marine Biopharmaceutical Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Marine Biopharmaceutical Revenue by Company (2020-2022) 6.2 North America Marine Biopharmaceutical Revenue by Type (2017-2028) 6.3 North America Marine Biopharmaceutical Revenue by Application (2017-2028) 6.4 North America Marine Biopharmaceutical Revenue by Country (2017-2028) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Marine Biopharmaceutical Revenue by Company (2020-2022) 7.2 Europe Marine Biopharmaceutical Revenue by Type (2017-2028) 7.3 Europe Marine Biopharmaceutical Revenue by Application (2017-2028) 7.4 Europe Marine Biopharmaceutical Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Marine Biopharmaceutical Revenue by Company (2020-2022) 8.2 Asia Pacific Marine Biopharmaceutical Revenue by Type (2017-2028) 8.3 Asia Pacific Marine Biopharmaceutical Revenue by Application (2017-2028) 8.4 Asia Pacific Marine Biopharmaceutical Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 China Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 9 Latin America 9.1 Latin America Marine Biopharmaceutical Revenue by Company (2020-2022) 9.2 Latin America Marine Biopharmaceutical Revenue by Type (2017-2028) 9.3 Latin America Marine Biopharmaceutical Revenue by Application (2017-2028) 9.4 Latin America Marine Biopharmaceutical Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Marine Biopharmaceutical Revenue by Company (2020-2022) 10.2 Middle East and Africa Marine Biopharmaceutical Revenue by Type (2017-2028) 10.3 Middle East and Africa Marine Biopharmaceutical Revenue by Application (2017-2028) 10.4 Middle East and Africa Marine Biopharmaceutical Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 Seattle Genetics 11.1.1 Seattle Genetics Company Details 11.1.2 Seattle Genetics Business Overview 11.1.3 Seattle Genetics Marine Biopharmaceutical Products and Services 11.1.4 Seattle Genetics Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.1.5 Seattle Genetics Marine Biopharmaceutical SWOT Analysis 11.1.6 Seattle Genetics Recent Developments 11.2 DSM 11.2.1 DSM Company Details 11.2.2 DSM Business Overview 11.2.3 DSM Marine Biopharmaceutical Products and Services 11.2.4 DSM Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.2.5 DSM Marine Biopharmaceutical SWOT Analysis 11.2.6 DSM Recent Developments 11.3 Eisai Co 11.3.1 Eisai Co Company Details 11.3.2 Eisai Co Business Overview 11.3.3 Eisai Co Marine Biopharmaceutical Products and Services 11.3.4 Eisai Co Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.3.5 Eisai Co Marine Biopharmaceutical SWOT Analysis 11.3.6 Eisai Co Recent Developments 11.4 Takeda 11.4.1 Takeda Company Details 11.4.2 Takeda Business Overview 11.4.3 Takeda Marine Biopharmaceutical Products and Services 11.4.4 Takeda Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.4.5 Takeda Marine Biopharmaceutical SWOT Analysis 11.4.6 Takeda Recent Developments 11.5 BASF 11.5.1 BASF Company Details 11.5.2 BASF Business Overview 11.5.3 BASF Marine Biopharmaceutical Products and Services 11.5.4 BASF Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.5.5 BASF Marine Biopharmaceutical SWOT Analysis 11.5.6 BASF Recent Developments 11.6 Amway 11.6.1 Amway Company Details 11.6.2 Amway Business Overview 11.6.3 Amway Marine Biopharmaceutical Products and Services 11.6.4 Amway Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.6.5 Amway Marine Biopharmaceutical SWOT Analysis 11.6.6 Amway Recent Developments 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Marine Biopharmaceutical Products and Services 11.7.4 Pfizer Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.7.5 Pfizer Marine Biopharmaceutical SWOT Analysis 11.7.6 Pfizer Recent Developments 11.8 Pelagia (EPAX) 11.8.1 Pelagia (EPAX) Company Details 11.8.2 Pelagia (EPAX) Business Overview 11.8.3 Pelagia (EPAX) Marine Biopharmaceutical Products and Services 11.8.4 Pelagia (EPAX) Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.8.5 Pelagia (EPAX) Marine Biopharmaceutical SWOT Analysis 11.8.6 Pelagia (EPAX) Recent Developments 11.9 Pharma Mar SA 11.9.1 Pharma Mar SA Company Details 11.9.2 Pharma Mar SA Business Overview 11.9.3 Pharma Mar SA Marine Biopharmaceutical Products and Services 11.9.4 Pharma Mar SA Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.9.5 Pharma Mar SA Marine Biopharmaceutical SWOT Analysis 11.9.6 Pharma Mar SA Recent Developments 11.10 Croda 11.10.1 Croda Company Details 11.10.2 Croda Business Overview 11.10.3 Croda Marine Biopharmaceutical Products and Services 11.10.4 Croda Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.10.5 Croda Marine Biopharmaceutical SWOT Analysis 11.10.6 Croda Recent Developments 11.11 GNC 11.11.1 GNC Company Details 11.11.2 GNC Business Overview 11.11.3 GNC Marine Biopharmaceutical Products and Services 11.11.4 GNC Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.11.5 GNC Recent Developments 11.12 GSK 11.12.1 GSK Company Details 11.12.2 GSK Business Overview 11.12.3 GSK Marine Biopharmaceutical Products and Services 11.12.4 GSK Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.12.5 GSK Recent Developments 11.13 TerSera Therapeutics 11.13.1 TerSera Therapeutics Company Details 11.13.2 TerSera Therapeutics Business Overview 11.13.3 TerSera Therapeutics Marine Biopharmaceutical Products and Services 11.13.4 TerSera Therapeutics Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.13.5 TerSera Therapeutics Recent Developments 11.14 Nordic Naturals 11.14.1 Nordic Naturals Company Details 11.14.2 Nordic Naturals Business Overview 11.14.3 Nordic Naturals Marine Biopharmaceutical Products and Services 11.14.4 Nordic Naturals Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.14.5 Nordic Naturals Recent Developments 11.15 Carlson Labs 11.15.1 Carlson Labs Company Details 11.15.2 Carlson Labs Business Overview 11.15.3 Carlson Labs Marine Biopharmaceutical Products and Services 11.15.4 Carlson Labs Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) 11.15.5 Carlson Labs Recent Developments 12 Marine Biopharmaceutical Market Dynamics 12.1 Marine Biopharmaceutical Market Trends 12.2 Marine Biopharmaceutical Market Drivers 12.3 Marine Biopharmaceutical Market Challenges 12.4 Marine Biopharmaceutical Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Marine Biopharmaceutical Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Drugs Table 3. Key Players of Health Supplement Table 4. Global Marine Biopharmaceutical Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Marine Biopharmaceutical Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global Marine Biopharmaceutical Revenue by Region (2017-2022) & (US$ Million) Table 7. Global Marine Biopharmaceutical Revenue Market Share by Region (2017-2022) Table 8. Global Marine Biopharmaceutical Revenue by Players (2017-2022) & (US$ Million) Table 9. Global Marine Biopharmaceutical Market Share by Players (2017-2022) Table 10. Global Top Marine Biopharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Biopharmaceutical as of 2021) Table 11. Ranking of Global Top Marine Biopharmaceutical Companies by Revenue (US$ Million) in 2021 Table 12. Global 5 Largest Players Market Share by Marine Biopharmaceutical Revenue (CR5 and HHI) & (2017-2022) Table 13. Key Players Headquarters and Area Served Table 14. Key Players Marine Biopharmaceutical Product Solution and Service Table 15. Date of Key Manufacturers Enter into Marine Biopharmaceutical Market Table 16. Mergers & Acquisitions, Expansion Plans Table 17. Global Marine Biopharmaceutical Market Size by Type (2017-2022) & (US$ Million) Table 18. Global Marine Biopharmaceutical Revenue Market Share by Type (2017-2022) Table 19. Global Marine Biopharmaceutical Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 20. Global Marine Biopharmaceutical Revenue Market Share by Type (2023-2028) Table 21. Global Marine Biopharmaceutical Market Size by Application (2017-2022) & (US$ Million) Table 22. Global Marine Biopharmaceutical Revenue Market Share by Application (2017-2022) Table 23. Global Marine Biopharmaceutical Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 24. Global Marine Biopharmaceutical Revenue Market Share by Application (2023-2028) Table 25. North America Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million) Table 26. North America Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million) Table 27. North America Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million) Table 28. North America Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million) Table 29. North America Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million) Table 30. North America Marine Biopharmaceutical Revenue by Country (2017-2022) & (US$ Million) Table 31. North America Marine Biopharmaceutical Revenue by Country (2023-2028) & (US$ Million) Table 32. Europe Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million) Table 33. Europe Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million) Table 34. Europe Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million) Table 35. Europe Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million) Table 36. Europe Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million) Table 37. Europe Marine Biopharmaceutical Revenue by Country (2017-2022) & (US$ Million) Table 38. Europe Marine Biopharmaceutical Revenue by Country (2023-2028) & (US$ Million) Table 39. Asia Pacific Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million) Table 40. Asia Pacific Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million) Table 41. Asia Pacific Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million) Table 42. Asia Pacific Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million) Table 43. Asia Pacific Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million) Table 44. Asia Pacific Marine Biopharmaceutical Revenue by Region (2017-2022) & (US$ Million) Table 45. Asia Pacific Marine Biopharmaceutical Revenue by Region (2023-2028) & (US$ Million) Table 46. Latin America Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million) Table 47. Latin America Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million) Table 48. Latin America Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million) Table 49. Latin America Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million) Table 50. Latin America Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million) Table 51. Latin America Marine Biopharmaceutical Revenue by Country (2017-2022) & (US$ Million) Table 52. Latin America Marine Biopharmaceutical Revenue by Country (2023-2028) & (US$ Million) Table 53. Middle East and Africa Marine Biopharmaceutical Revenue by Company (2020-2022) & (US$ Million) Table 54. Middle East and Africa Marine Biopharmaceutical Revenue by Type (2017-2022) & (US$ Million) Table 55. Middle East and Africa Marine Biopharmaceutical Revenue by Type (2023-2028) & (US$ Million) Table 56. Middle East and Africa Marine Biopharmaceutical Revenue by Application (2017-2022) & (US$ Million) Table 57. Middle East and Africa Marine Biopharmaceutical Revenue by Application (2023-2028) & (US$ Million) Table 58. Middle East and Africa Marine Biopharmaceutical Revenue by Country (2017-2022) & (US$ Million) Table 59. Middle East and Africa Marine Biopharmaceutical Revenue by Country (2023-2028) & (US$ Million) Table 60. Seattle Genetics Company Details Table 61. Seattle Genetics Business Overview Table 62. Seattle Genetics Marine Biopharmaceutical Product and Services Table 63. Seattle Genetics Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 64. Seattle Genetics Marine Biopharmaceutical SWOT Analysis Table 65. Seattle Genetics Recent Developments Table 66. DSM Company Details Table 67. DSM Business Overview Table 68. DSM Marine Biopharmaceutical Product and Services Table 69. DSM Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 70. DSM Marine Biopharmaceutical SWOT Analysis Table 71. DSM Recent Developments Table 72. Eisai Co Company Details Table 73. Eisai Co Business Overview Table 74. Eisai Co Marine Biopharmaceutical Product and Services Table 75. Eisai Co Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 76. Eisai Co Marine Biopharmaceutical SWOT Analysis Table 77. Eisai Co Recent Developments Table 78. Takeda Company Details Table 79. Takeda Business Overview Table 80. Takeda Marine Biopharmaceutical Product and Services Table 81. Takeda Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 82. Takeda Marine Biopharmaceutical SWOT Analysis Table 83. Takeda Recent Developments Table 84. BASF Company Details Table 85. BASF Business Overview Table 86. BASF Marine Biopharmaceutical Product and Services Table 87. BASF Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 88. BASF Marine Biopharmaceutical SWOT Analysis Table 89. BASF Recent Developments Table 90. Amway Company Details Table 91. Amway Business Overview Table 92. Amway Marine Biopharmaceutical Product and Services Table 93. Amway Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 94. Amway Marine Biopharmaceutical SWOT Analysis Table 95. Amway Recent Developments Table 96. Pfizer Company Details Table 97. Pfizer Business Overview Table 98. Pfizer Marine Biopharmaceutical Product and Services Table 99. Pfizer Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 100. Pfizer Marine Biopharmaceutical SWOT Analysis Table 101. Pfizer Recent Developments Table 102. Pelagia (EPAX) Company Details Table 103. Pelagia (EPAX) Business Overview Table 104. Pelagia (EPAX) Marine Biopharmaceutical Product and Services Table 105. Pelagia (EPAX) Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 106. Pelagia (EPAX) Marine Biopharmaceutical SWOT Analysis Table 107. Pelagia (EPAX) Recent Developments Table 108. Pharma Mar SA Company Details Table 109. Pharma Mar SA Business Overview Table 110. Pharma Mar SA Marine Biopharmaceutical Product and Services Table 111. Pharma Mar SA Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 112. Pharma Mar SA Marine Biopharmaceutical SWOT Analysis Table 113. Pharma Mar SA Recent Developments Table 114. Croda Company Details Table 115. Croda Business Overview Table 116. Croda Marine Biopharmaceutical Product and Services Table 117. Croda Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 118. Croda Marine Biopharmaceutical SWOT Analysis Table 119. Croda Recent Developments Table 120. GNC Company Details Table 121. GNC Business Overview Table 122. GNC Marine Biopharmaceutical Product and Services Table 123. GNC Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 124. GNC Recent Developments Table 125. GSK Company Details Table 126. GSK Business Overview Table 127. GSK Marine Biopharmaceutical Product and Services Table 128. GSK Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 129. GSK Recent Developments Table 130. TerSera Therapeutics Company Details Table 131. TerSera Therapeutics Business Overview Table 132. TerSera Therapeutics Marine Biopharmaceutical Product and Services Table 133. TerSera Therapeutics Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 134. TerSera Therapeutics Recent Developments Table 135. Nordic Naturals Company Details Table 136. Nordic Naturals Business Overview Table 137. Nordic Naturals Marine Biopharmaceutical Product and Services Table 138. Nordic Naturals Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 139. Nordic Naturals Recent Developments Table 140. Carlson Labs Company Details Table 141. Carlson Labs Business Overview Table 142. Carlson Labs Marine Biopharmaceutical Product and Services Table 143. Carlson Labs Marine Biopharmaceutical Revenue in Marine Biopharmaceutical Business (2017-2022) & (US$ Million) Table 144. Carlson Labs Recent Developments Table 145. Marine Biopharmaceutical Market Trends Table 146. Marine Biopharmaceutical Market Drivers Table 147. Marine Biopharmaceutical Market Challenges Table 148. Marine Biopharmaceutical Market Restraints Table 149. Research Programs/Design for This Report Table 150. Key Data Information from Secondary Sources Table 151. Key Data Information from Primary Sources List of Figures Figure 1. Global Marine Biopharmaceutical Sales Market Share by Type: 2021 VS 2028 Figure 2. Drugs Features Figure 3. Health Supplement Features Figure 4. Global Marine Biopharmaceutical Sales Market Share by Application: 2021 VS 2028 Figure 5. Hospital & Clinic Case Studies Figure 6. Pharmacy Case Studies Figure 7. Other Case Studies Figure 8. Marine Biopharmaceutical Report Years Considered Figure 9. Global Marine Biopharmaceutical Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Marine Biopharmaceutical Market Size 2017-2028 (US$ Million) Figure 11. Global Marine Biopharmaceutical Market Size Market Share by Region: 2021 VS 2028 Figure 12. Global Marine Biopharmaceutical Revenue Market Share by Region in 2017 VS 2022 Figure 13. Global Top 10 Marine Biopharmaceutical Countries Ranking by Market Size (US$ Million) in 2021 Figure 14. Global Marine Biopharmaceutical Market Share by Players in 2021 Figure 15. Global Top Marine Biopharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marine Biopharmaceutical as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Marine Biopharmaceutical Revenue in 2021 Figure 17. North America Marine Biopharmaceutical Revenue Market Share by Company in 2021 Figure 18. North America Marine Biopharmaceutical Revenue Market Share by Type (2017-2028) Figure 19. North America Marine Biopharmaceutical Revenue Market Share by Application (2017-2028) Figure 20. North America Marine Biopharmaceutical Revenue Share by Country (2017-2028) Figure 21. United States Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 22. Canada Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 23. Europe Marine Biopharmaceutical Revenue Market Share by Company in 2021 Figure 24. Europe Marine Biopharmaceutical Revenue Market Share by Type (2017-2028) Figure 25. Europe Marine Biopharmaceutical Revenue Market Share by Application (2017-2028) Figure 26. Europe Marine Biopharmaceutical Revenue Share by Country (2017-2028) Figure 27. Germany Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 28. France Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 29. U.K. Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 30. Italy Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 31. Russia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 32. Asia Pacific Marine Biopharmaceutical Revenue Market Share by Company in 2021 Figure 33. Asia Pacific Marine Biopharmaceutical Revenue Market Share by Type (2017-2028) Figure 34. Asia Pacific Marine Biopharmaceutical Revenue Market Share by Application (2017-2028) Figure 35. Asia Pacific Marine Biopharmaceutical Revenue Share by Region (2017-2028) Figure 36. China Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 37. Japan Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 38. South Korea Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 39. India Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 40. Australia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 41. China Taiwan Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 42. Indonesia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 43. Thailand Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 44. Malaysia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 45. Latin America Marine Biopharmaceutical Revenue Market Share by Company in 2021 Figure 46. Latin America Marine Biopharmaceutical Revenue Market Share by Type (2017-2028) Figure 47. Latin America Marine Biopharmaceutical Revenue Market Share by Application (2017-2028) Figure 48. Latin America Marine Biopharmaceutical Revenue Share by Country (2017-2028) Figure 49. Mexico Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 50. Brazil Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 51. Argentina Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 52. Middle East and Africa Marine Biopharmaceutical Revenue Market Share by Company in 2021 Figure 53. Middle East and Africa Marine Biopharmaceutical Revenue Market Share by Type (2017-2028) Figure 54. Middle East and Africa Marine Biopharmaceutical Revenue Market Share by Application (2017-2028) Figure 55. Middle East and Africa Marine Biopharmaceutical Revenue Share by Country (2017-2028) Figure 56. Turkey Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 57. Saudi Arabia Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 58. UAE Marine Biopharmaceutical Revenue (2017-2028) & (US$ Million) Figure 59. Seattle Genetics Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 60. DSM Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 61. Eisai Co Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 62. Takeda Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 63. BASF Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 64. Amway Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 65. Pfizer Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 66. Pelagia (EPAX) Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 67. Pharma Mar SA Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 68. Croda Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 69. GNC Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 70. GSK Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 71. TerSera Therapeutics Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 72. Nordic Naturals Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 73. Carlson Labs Revenue Growth Rate in Marine Biopharmaceutical Business (2017-2022) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Seattle Genetics DSM Eisai Co Takeda BASF Amway Pfizer Pelagia (EPAX) Pharma Mar SA Croda GNC GSK TerSera Therapeutics Nordic Naturals Carlson Labs